Towards a molecular and neurobiological understanding of mental health and mental illness for the benefit of citizens and patients

Last updated: 16.7.2025
Grant

This Horizon Europe funding program aimed to significantly advance the molecular and neurobiological understanding of mental health and mental illness. It sought to uncover the complex interactions of genetic, epigenetic, and environmental factors to drive innovative prevention and treatment strategies, ultimately benefiting citizens and patients across Europe and internationally.

Who is Funded

This section details the types of entities and geographical scope eligible for funding, focusing on collaborative, multidisciplinary research aimed at improving mental health outcomes for citizens and patients.

What is Funded

This section outlines the types of projects and thematic areas supported, emphasizing research that contributes to a deeper understanding of mental health conditions, biomarker identification, and the development of new treatments. Projects should cover various stages of the innovation cycle.

Type and Scope of Funding

This section details the financial support provided, specifically highlighting the grant-based funding model and the significant maximum funding amount available per project to foster impactful research.

Conditions and Requirements

This section specifies the critical conditions for applicants and projects, including administrative, financial, and ethical considerations, along with requirements for collaboration and data management.

Application Procedure

This section outlines the procedural steps for submitting proposals and the subsequent evaluation process, providing an overview of how applications are handled and decisions communicated.

This section identifies the core legal and policy documents that authorize and govern the funding program, ensuring transparency and adherence to established European Union frameworks.

Similar Programs

#Mental Health Research#Neurobiological Understanding#Mental Illness Treatment#Horizon Europe Funding#Health Innovation#Biomarker Discovery#Molecular Biology#Psychiatry#Genetic Factors#Epigenetic Factors#Environmental Risk#Pharmacological Interventions#Non-Pharmacological Therapies#Clinical Trials#AI in Healthcare#Public Health Policy#EU Research Grants#Patient Outcomes

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

10,000,000 €

Allocated Budget

Allocated Budget:

60,000,000 €

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union, United States of America, and other associated countries.

Sectors

Sectors:

Healthcare, Research and Development

Beneficiaries

Beneficiaries:

citizens and patients

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Pilot Testing

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Managed By:

European Commission

0 x 0
XS